Medication non-adherence to asthma and chronic obstructive pulmonary disease therapy
poses a significant burden for patients and societies. Non-adherence encompasses poor …

Asthma is a chronic inflammatory disease of the airways affecting more than 300 million
patients worldwide. The disease can be of various severity ranging from very mild to severe …

Background Regulatory bodies have approved five biologics for severe asthma. However,
regional differences in accessibility may limit the global potential for personalized medicine …

Background Asthma and chronic obstructive pulmonary disease (COPD) affect millions of
people worldwide. While medication can control and improve disease symptoms, incorrect …

BACKGROUND Medication non-adherence management of patients with asthma/COPD
remains challenging. Given the multitude of underlying causes, a personalized approach is …

Maintenance therapy delivered via inhaler is central to asthma and chronic obstructive
pulmonary disease (COPD) management. Poor adherence to inhaled medication and errors …

Introduction Asthma morbidity and health-care utilization are known to exhibit a steep
socioeconomic gradient. Further investigation into the modulators of this effect is required to …

Background Digital inhalers can monitor inhaler usage, support difficult-to-treat asthma
management, and inform step-up treatment decisions yet their economic value is unknown …

Abstract (250/250 words) Background Treatment guidelines recommend triple therapy for
patients with asthma who remain uncontrolled on inhaled corticosteroid/long-acting β 2 …

In many perinatal pharmacoepidemiologic studies, exposure to a medication is classified as
“ever exposed” versus “never exposed” within each trimester or even over the entire …